Artificial intelligence in rheumatoid arthritis: current status and future perspectives: a state-of-the-art review

S Momtazmanesh, A Nowroozi, N Rezaei - Rheumatology and Therapy, 2022 - Springer
Investigation of the potential applications of artificial intelligence (AI), including machine
learning (ML) and deep learning (DL) techniques, is an exponentially growing field in …

Interactions between systemic diseases and oral microbiota shifts in the aging community: A narrative review

SA Mosaddad, P Mahootchi, S Safari… - Journal of Basic …, 2023 - Wiley Online Library
As a gateway to general health and a diverse microbial habitat, the oral cavity is colonized
by numerous microorganisms such as bacteria, fungi, viruses, and archaea. Oral microbiota …

Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification

P Novielli, D Romano, M Magarelli, PD Bitonto… - Frontiers in …, 2024 - frontiersin.org
Background Colorectal cancer (CRC) is a type of tumor caused by the uncontrolled growth
of cells in the mucosa lining the last part of the intestine. Emerging evidence underscores an …

Gut dysbiosis in autoimmune diseases: association with mortality

SH Chang, Y Choi - Frontiers in Cellular and Infection Microbiology, 2023 - frontiersin.org
To better understand the impact of gut dysbiosis on four autoimmune diseases [Sjögren's
syndrome (SS), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple …

Pharmacogenomics of monoclonal antibodies for the treatment of rheumatoid arthritis

SH Lim, K Kim, CI Choi - Journal of Personalized Medicine, 2022 - mdpi.com
Precision medicine refers to a highly individualized and personalized approach to patient
care. Pharmacogenomics is the study of how an individual's genomic profile affects their …

Oral dysbiosis and systemic diseases

FM Georges, NT Do, D Seleem - Frontiers in dental medicine, 2022 - frontiersin.org
The aim of this mini review is to investigate the connection between oral microbiome
dysbiosis and systemic diseases. Many systemic conditions can have oral manifestations …

The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis

E Russo, S Bellando-Randone, D Carboni… - …, 2024 - academic.oup.com
Objectives We characterized the microbiota in SSc, focusing on the skin–oral–gut axis and
the serum and faecal free fatty acid (FFA) profile. Methods Twenty-five SSc patients with …

Electrochemical (bio) sensing devices for human-microbiome-related biomarkers

E Sánchez-Tirado, L Agüí, A González-Cortés… - Sensors, 2023 - mdpi.com
The study of the human microbiome is a multidisciplinary area ranging from the field of
technology to that of personalized medicine. The possibility of using microbiota biomarkers …

Exosome-derived microRNAs from mouthrinse have the potential to be novel biomarkers for Sjögren syndrome

K Yamashiro, T Hamada, K Mori, K Nishi… - Journal of Personalized …, 2022 - mdpi.com
Sjögren syndrome (SS) is diagnosed based on invasive tissue biopsies and blood sampling.
Therefore, a novel non-invasive and simple inspection diagnostic marker of SS is required …

The use and utility of machine learning in achieving precision medicine in systemic sclerosis: a narrative review

F Bonomi, S Peretti, G Lepri, V Venerito… - Journal of Personalized …, 2022 - mdpi.com
Background: Systemic sclerosis (SSc) is a rare connective tissue disease that can affect
different organs and has extremely heterogenous presentations. This complexity makes it …